This suggests that GLP-1 agonists could play a dual role: helping with weight and metabolic issues while also influencing autoimmune disease activity
The clinical concern is not about drug testing but about gastroparesis risk: semaglutide slows gastric emptying, which can increase aspiration risk under general anesthesia if fasting protocols are not appropriately extended
While originally developed for diabetes management, below are some of the most common GLP-1 medications prescribed for weight loss: Semaglutide (Ozempic, Wegovy, Rybelsus): One of the most popular options, semaglutide is highly effective for both diabetes and weight loss
Fibre-rich foods , particularly oats, barley, beans, lentils, fruit, and vegetables
McComsey at Case Western Reserve University